Similarly, SETD6 has been implicated as a marker in breast cancer stem cells, and its mutation is associated with increased susceptibility to familial colorectal cancer type X (Martín-Morales et al., 2017; Li et al., 2023). Here, SETD6 is linked to familial colorectal cancer type X.